Media coverage
65
Media coverage
Title Merck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease Media name/outlet Red Orbit Country United States Date 4/25/15 Persons Eric J Lawitz Title Merck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease Media name/outlet Morningstar.com Country United States Date 4/24/15 Persons Eric J Lawitz Title Merck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease Media name/outlet Financial Content Country United States Date 4/24/15 Persons Eric J Lawitz Title Merck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease Media name/outlet SearchBug Country United States Date 4/24/15 Persons Eric J Lawitz Title Merck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease Media name/outlet Industrial Info Financials Country United States Date 4/24/15 Persons Eric J Lawitz Title Merck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease Media name/outlet Town Hall Country United States Date 4/24/15 Persons Eric J Lawitz Title Merck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease Media name/outlet BioSpace Country United States Date 4/24/15 Persons Eric J Lawitz Title Merck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease Media name/outlet RCL Advisors Country United States Date 4/24/15 Persons Eric J Lawitz Title Merck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease Media name/outlet Franklin Credit Management Corporation Country United States Date 4/24/15 Persons Eric J Lawitz Title Merck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease Media name/outlet Reliance Trust Country United States Date 4/24/15 Persons Eric J Lawitz Title Merck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease Media name/outlet Market Pulse Navigator Country United States Date 4/24/15 Persons Eric J Lawitz Title Merck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease Media name/outlet WorldNetDaily Country United States Date 4/24/15 Persons Eric J Lawitz Title Merck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease Media name/outlet Marketplace Country United States Date 4/24/15 Persons Eric J Lawitz Title Merck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease Media name/outlet Fat Pitch Financials Country United States Date 4/24/15 Persons Eric J Lawitz Title Merck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease Media name/outlet Crawford Financial Planning Country United States Date 4/24/15 Persons Eric J Lawitz Title Merck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease Media name/outlet CEOWorld Magazine Country United States Date 4/24/15 Persons Eric J Lawitz Title Merck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease Media name/outlet Wall Street Business Network Country United States Date 4/24/15 Persons Eric J Lawitz Title Merck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease Media name/outlet Financial Content Country United States Date 4/24/15 Persons Eric J Lawitz Title Merck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease Media name/outlet TickerTech.com Country United States Date 4/24/15 Persons Eric J Lawitz Title Merck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease Media name/outlet Tamar Securities Country United States Date 4/24/15 Persons Eric J Lawitz Title Merck Announces Results from C-SURFER Phase 2/3 Study of Investigational Media name/outlet Finwin Country United States Date 4/24/15 Persons Eric J Lawitz Title Merck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease Media name/outlet TradingCharts.com Country United States Date 4/24/15 Persons Eric J Lawitz Title Merck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease Media name/outlet Good Day Sacramento Country United States Date 4/24/15 Persons Eric J Lawitz Title Merck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease Media name/outlet Stock Nod Country United States Date 4/24/15 Persons Eric J Lawitz Title Merck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease Media name/outlet Ask.com Country United States Date 4/24/15 Persons Eric J Lawitz Title Merck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease Media name/outlet KiiiTV3.com Country United States Date 4/24/15 Persons Eric J Lawitz Title Merck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease Media name/outlet KATV Country United States Date 4/24/15 Persons Eric J Lawitz Title Merck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease Media name/outlet CW Richmond WUPV Country United States Date 4/24/15 Persons Eric J Lawitz Title Merck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease Media name/outlet KMEG 14 Country United States Date 4/24/15 Persons Eric J Lawitz Title Merck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease Media name/outlet MyFoxTallahassee.com Country United States Date 4/24/15 Persons Eric J Lawitz Title Merck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease Media name/outlet FOX 14 TV Country United States Date 4/24/15 Persons Eric J Lawitz Title Merck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease Media name/outlet KTUL Country United States Date 4/24/15 Persons Eric J Lawitz Title Merck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease Media name/outlet KXNet.com Country United States Date 4/24/15 Persons Eric J Lawitz Title Merck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease Media name/outlet KAUZ Country United States Date 4/24/15 Persons Eric J Lawitz Title Merck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease Media name/outlet KSWO Country United States Date 4/24/15 Persons Eric J Lawitz Title Merck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease Media name/outlet 35 WSEE Country United States Date 4/24/15 Persons Eric J Lawitz Title Merck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease Media name/outlet KCEN HD Country United States Date 4/24/15 Persons Eric J Lawitz Title Merck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease Media name/outlet KMPH Fox 26 Country United States Date 4/24/15 Persons Eric J Lawitz Title Merck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease Media name/outlet Nebraska TV Country United States Date 4/24/15 Persons Eric J Lawitz Title Merck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease Media name/outlet KYTX CBS 19 Country United States Date 4/24/15 Persons Eric J Lawitz Title Merck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease Media name/outlet 12 News Now Country United States Date 4/24/15 Persons Eric J Lawitz Title Merck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease Media name/outlet Kuam News 8 Country Guam Date 4/24/15 Persons Eric J Lawitz Title Merck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease Media name/outlet GTN News Country United States Date 4/24/15 Persons Eric J Lawitz Title Merck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease Media name/outlet KFMB-TV Country United States Date 4/24/15 Persons Eric J Lawitz Title Merck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease Media name/outlet News 9 Country United States Date 4/24/15 Persons Eric J Lawitz Title Merck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease Media name/outlet ABC News 4 Charleston Country United States Date 4/24/15 Persons Eric J Lawitz Title Merck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease Media name/outlet Fox41.com Country United States Date 4/24/15 Persons Eric J Lawitz Title Merck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease Media name/outlet WCAX TV3 Country United States Date 4/24/15 Persons Eric J Lawitz Title Merck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease Media name/outlet KPTM FOX 42 Country United States Date 4/24/15 Persons Eric J Lawitz Title Merck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease Media name/outlet WBOY Country United States Date 4/24/15 Persons Eric J Lawitz Title Merck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease Media name/outlet WBOC TV 16 Country United States Date 4/24/15 Persons Eric J Lawitz Title Merck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease Media name/outlet KUSI.com Country United States Date 4/24/15 Persons Eric J Lawitz Title Merck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease Media name/outlet KRHD TV Country United States Date 4/24/15 Persons Eric J Lawitz Title Merck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease Media name/outlet KPLC TV Country United States Date 4/24/15 Persons Eric J Lawitz Title Merck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease Media name/outlet WVNS Country United States Date 4/24/15 Persons Eric J Lawitz Title Merck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease Media name/outlet WXTX Fox 54 Country Georgia Date 4/24/15 Persons Eric J Lawitz Title Merck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease Media name/outlet WSET Country United States Date 4/24/15 Persons Eric J Lawitz Title Merck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease Media name/outlet WLTZ 38 Country Georgia Date 4/24/15 Persons Eric J Lawitz Title Merck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease Media name/outlet AZ-TV7 Country United States Date 4/24/15 Persons Eric J Lawitz Title Merck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease Media name/outlet WAND TV Country United States Date 4/24/15 Persons Eric J Lawitz Title Merck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease Media name/outlet KNDO KNDU Country United States Date 4/24/15 Persons Eric J Lawitz Title Merck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease Media name/outlet ABC 3340 Country United States Date 4/24/15 Persons Eric J Lawitz Title Merck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease Media name/outlet WTRF Country United States Date 4/24/15 Persons Eric J Lawitz Title Merck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease Media name/outlet KSTC-TV Country United States Date 4/24/15 Persons Eric J Lawitz Title Merck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease Media name/outlet WSFX-TV Country United States Date 4/24/15 Persons Eric J Lawitz